{"organizations": [], "uuid": "25bc480c497742efd50776e6f58769acb3e960ec", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "blogs.wsj.com", "main_image": "http://s.wsj.net/blogs/img/WSJ_Logo_BlackBackground_1200x630social", "site_section": "http://blogs.wsj.com/moneybeat/feed/", "section_title": "MoneyBeat", "url": "https://blogs.wsj.com/moneybeat/2018/05/07/weight-gain-season-for-felines/", "country": "US", "domain_rank": 387, "title": "Weight Gain Season for Felines", "performance_score": 0, "site": "wsj.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-05-07T17:11:00.000+03:00", "replies_count": 0, "uuid": "25bc480c497742efd50776e6f58769acb3e960ec"}, "author": "Charley Grant", "url": "https://blogs.wsj.com/moneybeat/2018/05/07/weight-gain-season-for-felines/", "ord_in_thread": 0, "title": "Weight Gain Season for Felines", "locations": [], "entities": {"persons": [], "locations": [{"name": "mirataz", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "food and drug administration", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "0 COMMENTS Bring back the fat cats!\nKindred Biosciences , a biotech startup focused on developing medicines for pets, announced on Monday that the Food and Drug Administration has approved Mirataz, a drug that helps manage weight loss in felines.\n“Based on our market research, we estimate that veterinarians in the U.S. see as many as 9 million cats each year with unintended weight loss due to various underlying conditions.” CEO Richard Chin said in a press release.\nThat hefty number suggests a large market opportunity. Of course, Kindred will need to convert optimism into sales if it wants to maintain the momentum in the company’s stock price, which is up about 45% so far this year.\nA celebrity pitchman, or better yet pitchcat, might help. There was no word yet as of Monday morning-whether Garfield is available.\nShare this: Biotech Heard on the Street Overheard Previous The Warren Buffett-Elon Musk Feud Isn't Over Yet Next Stocks to Watch: Berkshire, Starbucks, Apple, Mondelez, Wells Fargo, Nvidia, Exxon, Blackstone", "external_links": [], "published": "2018-05-07T17:11:00.000+03:00", "crawled": "2018-05-07T16:24:05.001+03:00", "highlightTitle": ""}